There is an abundance of evidence indicating that the oral administration of sodium 13II-
iodide is of value in the management of well-differentiated thyroid cancers. The first step in …

This study presents 131I thyroid activity measurements of 56 employees of the Department
of Nuclear Medicine and Endocrine Oncology, Centre for Oncology in Gliwice. The research …

Patients administered with a therapeutic dose of 131 I for thyroid cancer treatment are
potential sources of unacceptably high radiation exposure to other individuals, particularly …

Radioiodine (131I iodide) has long been a safe, effective and widely used treatment in the
management of differentiated thyroid cancer (DTC). Concerns regarding stochastic …

Medical health physics is the profession dedicated to the protection of healthcare providers,
members of the public, and patients from unwarranted radiation exposure. Medical health …

Background: 131 I source is widely used in the treatment of hyperthyroidism and thyroid
cancers. 131 I emits both beta and gamma-rays. Radiation protection is considered for …

Aim To provide a comprehensive overview with regard to the hospitalization/discharge
planning and nursing staff requirements for the management of patients treated with …

Radiation protection is a leading and rapidly developing area of medical physics and society
as evidenced by the emphasis hospitals and medical organizations are placing on radiation …

Purpose: This study was performed to obtain a better understanding of the radiation
environment in an 131 I isolation room after the release of patients with metastasis from …

The treatment of thyroid cancer generally comprises total thyroidectomy and oral
administration of radioiodine (131I). One consideration in this therapy is the radiation …